BioSpace News Archive

Today, Infinity BiologiX (“IBX”), a next-generation central laboratory, announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) “Genomic Surveillance for SARS-CoV-2 Variants”, to provide genomic sequencing and new variant identification of samples of SARS-CoV-2, the virus that causes COVID-19.

Day One announces today the expansion of its executive team and Board of Directors.

Day One Biopharmaceuticals, LLC. Using new insights from the biology of pediatric cancer, Day One Biopharmaceuticals develops promising new oncology therapies that change outcomes for people of all ages. Today, Day One unveils its team, $60M Series A financing, and announces its first promising clinical-stage oncology treatment, which Day One acquired through Takeda Pharmaceutical Company Limited.

Covid-19 is an infectious disease that may lead to Acute Respiratory Distress Syndrome (ARDS) and respiratory dysfunction (Liu 2017)

Qilu Puget Sound Biotherapeutic Corp. (Sound Biologics), an emerging biotechnology company focused on developing a novel MabPair™ platform for antibody-based combination therapies for the treatment of cancer, inflammation and autoimmune disease, announced a clinical update on its first MabPair product PSB205 at the American Association for Cancer Research (AACR) Annual Meeting

Clinical-stage biotechnology firm Imvax Inc. has extended and expanded its lease with Keystone Property Group at the landmark former publishing house The Curtis, further validating the mission-critical features of The Curtis for life science companies, and positioning Imvax for its next phase of growth.

New Option Presents an Affordable and Less Invasive Method for Schools and Businesses Requiring Frequent Testing for Employees and Students

Medline announced preliminary results of a supply chain and advanced logistics solution created during the pandemic for the many customers working to improve their ability to handle future emergencies.

New Moon, the inaugural virtual Iftar celebration for St. Jude Children’s Research Hospital®, brings together Muslim Americans this Sunday, April 18, for an evening of fellowship and philanthropy to benefit the lifesaving mission of St. Jude: Finding cures. Saving children®.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry Lime Rickey, Golden Raspberry),